S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
Sodium depletion increases platelet and plasma catecholamines in hypertensive men.
TL;DR: Previously untreated 50-year-old men with mild to moderate essential hypertension were given a low sodium diet for 2 weeks and blood platelets may be an integrated measure of plasma catecholamine concentrations during variations caused by sodium depletion.
Journal ArticleDOI
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime.
Reinhold Kreutz,Sverre E. Kjeldsen,Michel Burnier,Krzysztof Narkiewicz,Suzanne Oparil,Giuseppe Mancia +5 more
TL;DR: The study ‘Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial’ should have produced over 150 000 long-term blood pressure measurements with a failure rate of less than 10%; which it cannot achieve in clinical use, not even with Spacelabs devices.
Journal ArticleDOI
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
Sverre E. Kjeldsen,Domenic A. Sica,Hermann Haller,Gloria Cha,Blas Gil-Extremera,Peter Harvey,Frank Heyvaert,Andrew J. Lewin,G. Villa,Giuseppe Mancia +9 more
TL;DR: N/C combination was effective in participants with hypertension and showed an improved side effect profile compared with N monotherapy, and combination therapy was similarly effective in different racial groups.
Journal ArticleDOI
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study.
Inger Ariansen,Henrik M. Reims,Knut Gjesdal,Michael H. Olsen,Hans Ibsen,Richard B. Devereux,Peter M. Okin,Sverre E. Kjeldsen,Björn Dahlöf,Kristian Wachtell +9 more
TL;DR: The data suggest that alcohol intake above this level may be marginally deleterious, while no effect of smoking on risk of AF was detected in hypertensive patients with LVH and there were no significant interactions between high alcohol intake and either smoking or gender on the risk of getting AF.
Journal ArticleDOI
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.
Fadl Elmula M. Fadl Elmula,Fadl Elmula M. Fadl Elmula,Anne Cecilie K Larstorp,Anne Cecilie K Larstorp,Sverre E. Kjeldsen,Sverre E. Kjeldsen,Alexandre Persu,Alexandre Persu,Yu Jin,Jan A. Staessen,Jan A. Staessen +10 more
TL;DR: The overall blood-pressure lowering effect of RDN seems rather limited and the characteristics of true responders are largely unknown, Accordingly, RDN is not ready for clinical practice.